CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $1.41B, above the global median of $1.15B
- PositionCurrent ratio is 9.82×, higher than 95% of its Medical Devices peers (median 2.76×)
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.11%
Annual Rate
CNY 0.02Paid unknown
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
Jun 12, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.51BCNY1.41B · vs all stocks (USD)
Trailing P/E
159.38xvs Medical Devices peers
Revenue (TTM)
486.36MCNY72.33M · vs all stocks (USD)
Profit Margin
12.81%vs Medical Devices peers
Beta
-0.3040xvs all stocks
52-Week Change
-23.51%vs all stocks
Forward Annual Dividend Yield
0.11%vs all stocks
Market Capitalization
9.51BCNY1.41B · vs all stocks (USD)
Enterprise Value
7.88BCNY1.17B · vs all stocks (USD)
Trailing P/E
159.38xvs Medical Devices peers
Forward P/E
121.14xvs Medical Devices peers
Price to Sales (TTM)
20.05xvs Medical Devices peers
Price to Book (MRQ)
5.40xvs Medical Devices peers
Enterprise to Revenue
16.20xvs Medical Devices peers
Enterprise to EBITDA
170.06xvs Medical Devices peers
Gross Margin
55.80%vs Medical Devices peers
Profit Margin
12.81%vs Medical Devices peers
Operating Margin
5.04%vs Medical Devices peers
Return on Assets (TTM)
0.49%vs Medical Devices peers
Return on Equity (TTM)
3.49%vs Medical Devices peers
Revenue (TTM)
486.36MCNY72.33M · vs all stocks (USD)
Revenue per Share (TTM)
1.03CNYUpdated Aug 21, 2026Quarterly Revenue Growth
21.00%vs Medical Devices peers
Gross Profit (TTM)
273.16MCNY40.62M · vs all stocks (USD)
EBITDA (TTM)
67.13MCNY9.98M · vs all stocks (USD)
Net Income (TTM)
62.30MCNY9.26M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
62.80%vs Medical Devices peers
Operating Cash Flow (TTM)
34.01MCNY5.06M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-16.13MCNY-2.40M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0200CNYUpdated Aug 21, 2026Forward Annual Dividend Yield
0.11%vs all stocks
Trailing Annual Dividend Rate
0.0210CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.11%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
464.53MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
195.22MCNYFY2025 · Dec 31, 2025Gross Profit
269.31MCNYFY2025 · Dec 31, 2025Operating Income
39.02MCNY5.80M · vs all stocks (USD)
Pre-tax Income
51.34MCNYFY2025 · Dec 31, 2025Income Tax Expense
260.59KCNYFY2025 · Dec 31, 2025Net Income
51.08MCNYFY2025 · Dec 31, 2025EBIT
51.64MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
84.36MCNYFY2025 · Dec 31, 2025Research & Development
64.08MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
71.19MCNYFY2025 · Dec 31, 2025Other Operating Expenses
3.53MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
4.06MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
300.07KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1085CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1085CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
470.80MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
470.80MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
51.08MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
5.99MCNYFY2025 · Dec 31, 2025Free Cash Flow
-116.24MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
276.52MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
51.08MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.22MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
117.46KCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-48.43MCNYFY2025 · Dec 31, 2025Capital Expenditures
-122.23MCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.88BCNYFY2025 · Dec 31, 2025Sale of Investments
4.92BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-77.86MCNYFY2025 · Dec 31, 2025Other Financing Charges
-5.08MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-5.08MCNYFY2025 · Dec 31, 2025Shares Outstanding
470.60MSharesUpdated Aug 21, 2026Float Shares
115.09MSharesUpdated Aug 21, 2026% Held by Insiders
40.04%vs all stocks
% Held by Institutions
39.42%vs all stocks
Total Cash (MRQ)
1.28BCNY190.11M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.72CNYUpdated Aug 21, 2026Total Debt (MRQ)
4.81MCNY715.77K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0027xvs Medical Devices peers
Current Ratio (MRQ)
9.82xvs Medical Devices peers
Book Value per Share (MRQ)
3.84CNYUpdated Aug 21, 2026Total Assets
1.99BCNY296.39M · vs all stocks (USD)
Total Current Assets
1.55BCNYFY2025 · Dec 31, 2025Total Liabilities
190.96MCNYFY2025 · Dec 31, 2025Total Non-current Assets
440.08MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
32.09MCNYFY2025 · Dec 31, 2025Total Current Liabilities
158.87MCNYFY2025 · Dec 31, 2025Cash
276.52MCNYFY2025 · Dec 31, 2025Cash Equivalents
0.00CNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
276.52MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.03BCNYFY2025 · Dec 31, 2025Accounts Receivable
77.99MCNYFY2025 · Dec 31, 2025Inventory
159.37MCNYFY2025 · Dec 31, 2025Accounts Payable
89.94MCNYFY2025 · Dec 31, 2025Short-term Debt
4.08MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.01MCNYFY2025 · Dec 31, 2025Long-term Debt
559.65KCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
10.35MCNYFY2025 · Dec 31, 2025Common Stock (Book)
470.60MCNYFY2025 · Dec 31, 2025Retained Earnings
48.23MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.80BCNY267.99M · vs all stocks (USD)
52-Week Low
18.67CNYUpdated Aug 21, 202652-Week High
28.26CNYUpdated Aug 21, 202652-Week Change
-23.51%vs all stocks
Beta
-0.3040xvs all stocks
50-Day MA
21.34CNYUpdated Aug 21, 2026200-Day MA
23.24CNYUpdated Aug 21, 2026Avg 10-Day Volume
3.81MSharesUpdated Aug 21, 2026Avg 30-Day Volume
4.27MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.1300CNYUpdated Aug 21, 20266 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Debt Falling While Share Count Rises
Debt has fallen for four years while the share count rose over eight.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
How does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
How is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 9.82×, higher than 95% of its Medical Devices peers (median 2.76×)Significant
Current ratio: 9.82Industry median: 2.76Industry P95: 8.20Peers compared: 59.00
P/E ratio is 159.38×, higher than 95% of its Medical Devices peers (median 35.3×)Significant
P/E ratio: 159.385Industry median: 35.30Industry P95: 117.323Peers compared: 59.00
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $1.41B, above the global median of $1.15BNotable
Market cap (USD): 1,413,655,105.2Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Chongqing Genrix Biopharma Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jiangxi Fushine Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Qingdao Haier Biomedical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Absci Corporation
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
KalVista Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
HBM Holdings Limited
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Shandong Xinhua Pharmaceutical Company Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
Inspire Medical Systems, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Vcanbio Cell & Gene Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Chongqing Taiji Industry Group Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Shenzhen Sinovatio Technology Co., Ltd.
5 interpretationsMinimal Tax and Interest DragPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And EquityLow-Leverage Liquidity ConfigurationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Zhubo Design Co. Ltd.
5 interpretationsMinimal Tax and Interest DragDebt Falling While Share Count RisesPrice Below Mean With Profitability And EquityLow-Leverage Liquidity ConfigurationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Shanghai Hajime Advanced Materials Co., Ltd.
5 interpretationsDebt Falling While Share Count RisesPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And EquityLow-Leverage Liquidity ConfigurationMulti-Year Debt Decrease With Cash Near Total Debt And Equity